definiens: shall mean any payments or other considera tion that BioLlne or an Affiliate of moUne actually recei ~ ed in conneclion with the sublicense ur uther arant of ri(l.bl~ wilh respocl 10 some ur all of ! he righl ! ! granled 10 Bioline under Soetion 5 I, or tile iflIIll of an option to obtain such sublicense or other rights, including witMot limitation royalties, license fees, mileslone payments, licen ~ e maintenance fees and CQ\lit ) ' ; provided Uull in the event thai BiuLine or an Affiliate of BioI - inc receives roon - monetary COl\!idetallOn fnr any such suhliceJlS < l Or other granl of rights or in the ca .,e of trallSIICtion$ root UI arm 's Icnstll, Sublicense Receipts stull be calculated based on Ihe f!lir market value of such oonsidenotion or l/'aJlS.aCuon, assuming an ann 's length l I I J I J I ] J : J 1 d ' J J I 1 . J ., J .I I I J tnlnSIICUOn made in tile ordinary CQw : Ie of busJDQS ; arul pru ~ tded further lhIIt Sublicensing Rcecipu wiU be rcdU«d by any amounts returned by BioLinc or an Affiliate 10 a Subli(l(:nscc . .... a<:c()unl of ' " pect of Sublicense Receipts . For the avoidantc of doubt, research grants received by BioLine ftom Wltional or international DOt.fQl"_profil funding bodies shall 1101 be considered Sublicensinll ~iplll